Equities Analysts Offer Predictions for DNLI FY2027 Earnings

Equities Analysts Offer Predictions for DNLI FY2027 Earnings

Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Stock analysts at HC Wainwright raised their FY2027 earnings per share (EPS) estimates for Denali Therapeutics in a research note issued to investors on Thursday, March 26th. HC Wainwright analyst A. Fein now anticipates that the company will post earnings of ($1.41) per share for the year, up from their prior estimate of ($1.52). HC Wainwright currently has a “Buy” rating and a $42.00 price…